Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Change in Acquisitions & Divestments (2016 - 2024)

AtriCure (ATRC) has disclosed Change in Acquisitions & Divestments for 15 consecutive years, with $8.0 million as the latest value for Q3 2024.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 48.39% to $8.0 million in Q3 2024 year-over-year; TTM through Jun 2025 was $8.0 million, a 86.92% decrease, with the full-year FY2024 number at $53.7 million, down 15.9% from a year prior.
  • Change in Acquisitions & Divestments was $8.0 million for Q3 2024 at AtriCure, down from $33.2 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $83.0 million in Q2 2021 to a low of $8.0 million in Q3 2024.
  • A 5-year average of $26.9 million and a median of $20.9 million in 2020 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 469.5% in 2021, then tumbled 65.47% in 2022.
  • AtriCure's Change in Acquisitions & Divestments stood at $25.3 million in 2020, then crashed by 35.57% to $16.3 million in 2021, then crashed by 31.52% to $11.2 million in 2022, then soared by 38.73% to $15.5 million in 2023, then tumbled by 48.39% to $8.0 million in 2024.
  • Per Business Quant, the three most recent readings for ATRC's Change in Acquisitions & Divestments are $8.0 million (Q3 2024), $33.2 million (Q2 2024), and $12.4 million (Q1 2024).